Replies to post #35765 on Kiwa Bio-Tech Products Group Corp (fka KWBT)

[MU_Redskin1]

It is what it is champ. This is a valued industry in China as substantiated by the numerous articles posted on this board. I am very familiar with this industry and believe that this company will survive or be acquired by another company in the same space.

Mistakes have been made by their accounting firm, which Friedman should remedy to save their reputation as a leading international accounting firm. Shit happens and I believe the fins will be audited, corrected and filed to return KWBT to pink current OTCQB status.

You have your opinion, we shareholders stand with the company until we are proven wrong. A company of this magnitude with a stellar past history is worth holding. I added 500k in the low .003s as well. A good bet imo.

It is a EWAG I’m willing to take!

Cheers and GLTA

Red

[buysellrepeat]

Look, here we are trading in the .003s. This company was pulling in revenues of $30-40m annually before covid. This is the OTC kid. If these prices, based off of pre covid numbers, don’t scream undervalued to you then have fun ever making it trading.

A legitimate company like KWBT can not be valued by 2020s numbers. This is a blip of the radar. As frustrating as this year has been I’ve been buying these levels.